Zevalin and haemoglobin decreased 
Zevalin and haemoglobin decreased Patient Reports February 12, 2012
Zevalin Side Effects Report #4840132-7
Zevalin side effect was reported by a Physician from UNITED STATES on Nov 11, 2005. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: body temperature increased, cholelithiasis, ecchymosis, electrocardiogram st-t segment abnormal, gastrointestinal stoma complication, haematocrit decreased, haemoglobin decreased, nodule, platelet count decreased. Zevalin dosage: unknown. During the same period patient was treated with AMARYL, ATROVENT, LASIX, PREVACID, CARTIA XT, DIGITEK, WARFARIN. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #4764425-7
Zevalin side effect was reported by a Physician from UNITED STATES on Aug 12, 2005. Male patient, 74 years of age, weighting 111.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bronchitis
, crepitations, disease progression, haemoglobin decreased, hypotension. Zevalin dosage: unknown. During the same period patient was treated with TYLENOL. Patient was hospitalized. Patient died on 08/01/2005.Zevalin Side Effects Report #5972684-8
Zevalin side effect was reported by a Health Professional from SPAIN on Nov 07, 2008. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspartate aminotransferase increased, blood albumin decreased, cardiac failure congestive, haemodialysis, haemoglobin decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, AMBISOME, ACYCLOVIR, NEUPOGEN, CYCLOSPORINE, FUROSEMIDE, VANCOMYCIN, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #4957620-5
Zevalin side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2006. Female patient, 61 years of age, weighting 193.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: diverticulum duodenal, haematocrit decreased, haemoglobin decreased, heart rate increased, herpes zoster, hypoaesthesia, influenza, injection site nodule, joint swelling. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARABINE, CYTOXAN, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #4854405-5
Zevalin side effect was reported by a Physician from GERMANY on July 14, 2005. Female patient, 58 years of age, weighting 120.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection
, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with BLOPRESS, RITUXAN, ADONA, CIPROXAN. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #4970447-3
Zevalin side effect was reported by a Physician from JAPAN on Mar 29, 2006. Female patient, 58 years of age, weighting 120.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection
, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with BLOPRESS, RITUXAN, ADONA, CIPROXAN. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5550377-9
Zevalin side effect was reported by a Health Professional from POLAND on Nov 23, 2007. Male patient, 67 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, red blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient died on 08/13/2005.
Zevalin Side Effects Report #5788870-6
Zevalin side effect was reported by a Consumer or non-health professional from GERMANY on Mar 07, 2008. Female patient, 61 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bacterial infection
, diarrhoea, empyema, granulocytopenia, haemoglobin decreased, hepatotoxicity, leukopenia, pleural effusion. Zevalin dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, KALINOR RETARD, BUSCOPAN, METOCLOPRAMIDE HYDROCHLORIDE, BISOPROLOL FUMARATE, MORPHINE SULPHATE, PANTOPRAZOLE, LASIX. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5192677-0
Zevalin side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Female patient, 83 years of age, weighting 135.8 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood magnesium decreased, fatigue, febrile neutropenia, haemoglobin decreased, neutrophil count decreased, pharyngeal erythema, platelet count decreased, rales, respiratory rate increased. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, THYROID, CYMBALTA, LIPITOR, PLAVIX, PREVACID, DARVON, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #4743349-5
Zevalin side effect was reported by a Physician from UNITED STATES on July 26, 2005. Female patient, 77 years of age, weighting 127.9 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: arthralgia, haemoglobin decreased, haemorrhage, headache
, red blood cell count decreased, thrombocytopenia, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, RITUXAN. Patient died on 07/12/2005.Zevalin Side Effects Report #5156704-9
Zevalin side effect was reported by a Physician from FRANCE on Oct 31, 2006. Male patient, 62 years of age, weighting 143.3 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood culture positive, clostridial infection, haemoglobin decreased, haemophilus infection, lung disorder, oral fungal infection, platelet count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5225190-2
Zevalin side effect was reported by a Health Professional from SWITZERLAND on Jan 15, 2007. Male patient, 59 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cough, engraftment syndrome, haemoglobin decreased, lung infiltration, pyrexia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, PARACETAMOL. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5233605-9
Zevalin side effect was reported by a Consumer or non-health professional from FRANCE on Jan 25, 2007. Male patient, 59 years of age, weighting 154.3 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bacillus infection, bronchopneumonia, haemoglobin decreased, haemoptysis, lung disorder, platelet count decreased, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, FILGRASTIM, AMOXICILLIN, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5133215-8
Zevalin side effect was reported by a Health Professional from SWITZERLAND on Oct 03, 2006. Male patient, 59 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cough, engraftment syndrome, haemoglobin decreased, lung infiltration, platelet count decreased, post procedural complication, pulmonary toxicity, pyrexia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5424462-6
Zevalin side effect was reported by a Health Professional from BELGIUM on Aug 06, 2007. Female patient, 59 years of age, weighting 178.6 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, pyrexia, viral infection
, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, CLARITHROMYCIN, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5424463-8
Zevalin side effect was reported by a Health Professional from BELGIUM on Aug 06, 2007. Female patient, 59 years of age, weighting 180.8 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: dermatitis, haemoglobin decreased, mucosal inflammation, platelet count decreased, respiratory failure, stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, OMEPRAZOLE. Patient recovered.
Zevalin Side Effects Report #5466955-1
Zevalin side effect was reported by a Health Professional from FRANCE on Sept 04, 2007. Male patient, 57 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: aspergillosis, bacteria stool identified, cholestasis, culture stool positive, escherichia infection, febrile neutropenia, haemoglobin decreased, hepatosplenomegaly, lung neoplasm. Zevalin dosage: unknown. During the same period patient was treated with TAZOCILLINE, FORTUM, RITUXAN, ETOPOSIDE, CYTARABINE, BICNU, ALKERAN. Patient recovered.
Zevalin Side Effects Report #5467947-9
Zevalin side effect was reported by a Health Professional from on Sept 07, 2007. Female patient, 55 years of age, weighting 127.9 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypoxia, neutropenia, pyrexia, thrombocytopenia, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, HEPARIN. Patient recovered.
Zevalin Side Effects Report #5040628-1
Zevalin side effect was reported by a Health Professional from FRANCE on June 12, 2006. Male patient, 52 years of age, weighting 145.5 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemoglobin decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, CYTARABINE, ETOPOSIDE, MELPHALAN, TRIFLUCAN, ZOVIRAX. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5035675-X
Zevalin side effect was reported by a Health Professional from FRANCE on June 06, 2006. Female patient, 47 years of age, weighting 158.7 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, diarrhoea, haemoglobin decreased, platelet count decreased, vomiting. Zevalin dosage: unknown. During the same period patient was treated with MABTHERA, CARMUSTINE, CYTARABINE, ETOPOSIDE, MELPHALAN. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5003405-3
Zevalin side effect was reported by a Health Professional from FRANCE on Apr 26, 2006. Female patient, 44 years of age, weighting 198.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: haemodialysis, haemoglobin decreased, renal failure acute. Zevalin dosage: unknown. During the same period patient was treated with ALIZAPRIDE, BENZNIDAZOLE, TRAMADOL, BENZODIAZEPINE DERIVATIVES, HEPARIN, POLARAMINE, ACYCLOVIR, PIPERACETAZINE. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #5009214-3
Zevalin side effect was reported by a Consumer or non-health professional from FRANCE on Mar 27, 2006. Female patient, 44 years of age, weighting 198.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: haemodialysis, haemoglobin decreased, renal failure acute. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, ARACYTINE, MELPHALAN, ALIZAPRIDE, BENZNIDAZOLE. Patient was hospitalized. Patient recovered.
Zevalin Side Effects Report #4892096-8
Zevalin side effect was reported by a Health Professional from GERMANY on Jan 05, 2006. Male patient, 31 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute respiratory failure, capnocytophagia infection, haemoglobin decreased, lung disorder, platelet count decreased, sepsis
, stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, ARACYTINE, MELPHALAN, NEFOPAM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #4942783-8
Zevalin side effect was reported by a Health Professional from GERMANY on Feb 23, 2006. Male patient, 31 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute respiratory failure, capnocytophagia infection, haematotoxicity, haemoglobin decreased, hypoxia, lung disorder, platelet count decreased, sepsis
, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, ARACYTINE, MELPHALAN, NEFOPAM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #4976029-1
Zevalin side effect was reported by a Health Professional from FRANCE on Mar 28, 2006. Male patient, 31 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute respiratory failure, capnocytophagia infection, febrile neutropenia, haemoglobin decreased, hypoxia, lung disorder, platelet count decreased, sepsis
, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, ARACYTINE, MELPHALAN, NEFOPAM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5223508-8
Zevalin side effect was reported by a Physician from UNITED STATES on Jan 12, 2007. Female patient, 83 years of age, weighting 135.8 lb, was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood magnesium decreased, erythema, fatigue, febrile neutropenia, haemoglobin decreased, herpes simplex
, parainfluenzae virus infection, rales, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, THYROID, CYMBALTA, LIPITOR, PLAVIX, PREVACID, DARVON, ALLOPURINOL. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #4895200-0
Zevalin side effect was reported by a Health Professional from GERMANY on Jan 09, 2006. Male patient, 47 years of age, weighting 189.6 lb, was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, haematotoxicity, haemoglobin decreased, platelet count decreased, sepsis
, stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ACYCLOVIR, CASPOFUNGIN, AMPHOTERICIN B, HEPARIN, PANTOPRAZOLE, MORPHINE. Patient recovered.